Search results
Nvidia Surges After First-Quarter Results; Is It A Buy Now?
Investor's Business Daily· 20 hours agoNvidia gapped to record highs after first-quarter results beat estimates yet again late Wednesday....
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 3 days agoHEALTH NEWS GSK’s experimental drug for asthma met its goals in the latest trial, moving a treatment...
Efforts to draw film industry to Kansas may not be the blockbuster lawmakers envision
The Topeka Capital-Journal via Yahoo Finance· 6 days agoHollywood has gotten very good at recycling old ideas and relying on blockbusters. In a sense, film...
Nvidia's First Quarter Results Confirm That The Next Industrial Revolution Is Well Underway
Benzinga via Yahoo Finance· 15 hours agoOn Wednesday, Nvidia Corporation (NASDAQ: NVDA) reported its fiscal first quarter results,...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Market Watch· 3 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than...
‘We’re Still Here’: How AMC Theatres Is Struggling With $4.5 Billion in Debt and Surviving Thanks to...
Variety via Yahoo Finance· 20 hours agoAdam Aron, the CEO of AMC Theatres, gives me a choice. We’re supposed to have a 20-minute interview...
Super Micro Computer Stock Fell Today Despite Nvidia's Blockbuster Quarter -- Is This a Buying...
The Motley Fool· 14 hours agoSuper Micro Computer (SMCI -2.96%) stock fell in Thursday's trading. The server specialist's share price closed out the daily session down 3%, according to data from S&P Global Market Intelligence ...
Love Selling Sunset? You’ll not want to miss new Netflix show Buying London
South China Morning Post· 15 hours agoOn the show, West Londoner Rosi Walden (who had a stint on reality show Made in Chelsea), top agent...
US FDA approves two biosimilars for blockbuster eye drug Eylea
AOL· 4 days agoThe agency approved Biocon Biologics' Yesafili as well as Samsung Bioepis and Biogen's Opuviz, while also allowing interchangeability, or the drug's substitution with biosimilars without the ...
Nvidia's stock split isn't something for investors to ignore: Morning Brief
AOL· 45 minutes agoThe number of Nvidia shares outstanding goes up and the per-share price goes down; there is no change in the value of the business. Data from Bank of America cited by TKer showed the average ...